Eterna Therapeutics Inc
ERNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.44M
Close$
$5.53
21.7% upside
Current Fair Value
21.7% upsideUndervalued by 21.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.44 Million |
|---|---|
| Enterprise Value | $-3,243,453.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-56 |
| Beta | 2.56 |
| Outstanding Shares | 1,183,000 |
Return
| Return on Equity | -383.28% |
|---|---|
| Return on Assets | -194.22% |
| Return on Invested Capital | -323.59% |
Valuation & Multiples
| P/E Ratio | -0.24 |
|---|---|
| PEG | -0.88 |
| Price to Sales | - |
| Price to Book Ratio | 2.27 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.3 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.11 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-3.30
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$-3.84
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 18.05%▲ 11.40% |
|---|---|
| Total Invested | $711,400▲ 13.44% |
| Investors Holding | 19▲ 5.00% |
ESG Score
No data
About Eterna Therapeutics Inc
2,018 employees